Phosphoenix

Raised $1.5M, announced 18 September 2026.

Round

Phosphoenix completed a €1.3 million financing round to prepare for its first-in-human clinical study and further develop its neurostimulation system.

Amount: $1.5M
Announced: 18 September 2026
Investors: TTT Medtech Fund (managed by 819 Capital), FIRST Fund (managed by BioGeneration Ventures), Innovatiefonds Noord-Holland, ROM InWest
Checked: Amount and date checked against the press source

Company

Develops neuroprosthetic systems to restore functional vision for blind people

Based in: Amsterdam, Netherlands
Sector: Other
Website: phosphoenix.nl ↗

Sources and links

Source: Amsterdam’s Phosphoenix raises €1.3 million to advance neuroprosthesis for profound blindness eu-startups.com
Website: phosphoenix.nl ↗

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost